Considering 30-days investment horizon, Merck & Inc. is expected to under-perform the Eli Lilly. In addition to that, Merck is 1.15 times more volatile than Eli Lilly &. It trades about -0.13 of its total potential returns per unit of risk. Eli Lilly & is currently generating about 0.04 per unit of volatility. If you would invest 4,130 in Eli Lilly & on April 26, 2012 and sell it today you would lose (19.00) from holding Eli Lilly & or give up 0.46% of portfolio value over 30 days.
Diversification
Very weak diversification
Overlapping area represents amount of risk that can be diversified away by holding Merck & Co. Inc. and Eli Lilly & Co. in the same portfolio (assuming nothing else is changed)
99% of all equities and portfolios perform better than Eli Lilly &. Compared with the overall equity markets, risk-adjusted returns on investments in Eli Lilly & are ranked lower than 1 (%) of all global equities and portfolios over the last 30 days.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
